Clinical Trial

Analyzing Pulsed Reduced Dose Radiotherapy in Upfront Glioblastoma

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The primary protocol objective is to assess the impact of substituting pulsed reduced dose radiotherapy (pRDR) for standard radiation therapy in the upfront treatment of glioblastoma (GBM) on disease progression.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-02-06; most recent amendment 2025-08-15.
Status change: Recruiting → Active, Not Recruiting 2024-10-22
Status change: Not Yet Recruiting → Recruiting 2021-07-06
Trial Details
NCT Number NCT04747145
Lead Sponsor Medical College of Wisconsin
Conditions Glioblastoma
Enrollment 38 participants
Start Date 2021-06-03
Primary Completion 2025-03-05 (estimated)
Study Completion 2027-09 (estimated)
Updated on ClinicalTrials.gov 2025-08-21